Cargando…
In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
The involvement of toll-like receptor 9 (TLR9), a receptor for bacterial DNA, in septic cardiac depression has not been clarified in vivo. Thus, the aim of the study was to test possible TLR9 inhibitors (H154-thioate, IRS954-thioate, and chloroquine) for their ability to protect the cardiovascular s...
Autores principales: | Boehm, O., Markowski, P., van der Giet, M., Gielen, V., Kokalova, A., Brill, C., Hoeft, A., Baumgarten, G., Meyer, R., Knuefermann, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649709/ https://www.ncbi.nlm.nih.gov/pubmed/23690658 http://dx.doi.org/10.1155/2013/217297 |
Ejemplares similares
-
Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury
por: Hilbert, Tobias, et al.
Publicado: (2018) -
Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
por: Markowski, P., et al.
Publicado: (2013) -
CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
por: Knuefermann, Pascal, et al.
Publicado: (2007) -
Vascular Dysfunction following Polymicrobial Sepsis: Role of Pattern Recognition Receptors
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2012) -
Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides
por: Pan, Xichun, et al.
Publicado: (2016)